Correlation of syndecan gene amplification with metastatic potential and clinical outcomes in carcinomas
American Journal of Physiology-Cell Physiology · 2024
DOI: 10.1152/ajpcell.00270.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Sewoon Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Sensor Technology, Easytem Co., Ltd., Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Gene Amplification. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: THE NATIONAL RESEARCH FOUNDATION OF KOREA GRANT FUNDED BY THE KOREA GOVERNMENT (MSIP), National Research Foundation of Korea.
Abstract (Originalsprache)
Cell surface receptors play crucial roles in cellular responses to extracellular ligands, helping to modulate the functions of a cell based on information coming from outside the cell. Syndecan refers to a family of cell adhesion receptors that regulate both extracellular and cytosolic events. Alteration of syndecan expression disrupts regulatory mechanisms in a cell type-specific fashion, often leading to serious diseases, notably cancer. Given the multifaceted functions and distinct tissue distributions of syndecan, it will be important to unravel the gene-level intricacies of syndecan expression and thereby further understand its involvement in various carcinogenic processes. Although accumulating evidence indicates that the protein expression patterns of syndecan family members are significantly altered in cancer cells, the underlying gene-level mechanisms remain largely unknown. This review endeavors to explore syndecan gene expression levels across different cancer types by scrutinizing extensive cancer genome datasets using tools such as cBioPortal. Our analysis unveils that somatic mutations in SDC genes are rare occurrences, whereas copy number alterations are frequently observed across diverse cancers, particularly in SDC2 and SDC4. Notably, amplifications of SDC2 and SDC4 correlate with heightened metastatic potential and dismal prognosis. This underscores the recurrent nature of SDC2 and SDC4 amplifications during carcinogenesis and sheds light on their role in promoting cancer activity through augmented protein expression. The identification of these amplifications not only enriches our understanding of carcinogenic mechanisms but also hints at the potential therapeutic avenue of targeting SDC2 and SDC4 to curb cancer cell proliferation and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Sensor Technology, Easytem Co., Ltd., Seoul, Republic of Korea.
- Department of Life Sciences, Ewha Womans University, Seoul, Republic of Korea.
- Department of Biomedical Science, Program in Biomedical Science and Engineering, College of Medicine, Inha University, Incheon, Republic of Korea.
ORCID-Profile: Inn-Oc Han, Eok-Soo Oh
Förderung
- THE NATIONAL RESEARCH FOUNDATION OF KOREA GRANT FUNDED BY THE KOREA GOVERNMENT (MSIP)
- National Research Foundation of Korea
Zitieren
APA
Kim, S., Yang, H., Cho, S., Jang, Y., Han, I. O., & Oh, E. S. (2024). Correlation of syndecan gene amplification with metastatic potential and clinical outcomes in carcinomas. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00270.2024
Vancouver
Kim S, Yang H, Cho S, Jang Y, Han IO, Oh ES. Correlation of syndecan gene amplification with metastatic potential and clinical outcomes in carcinomas. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00270.2024
BibTeX
@article{Kim2024,
author = {Kim, Sewoon and Yang, Hyeonju and Cho, Subin and Jang, Yunjung and Han, Inn-Oc and Oh, Eok-Soo},
title = {Correlation of syndecan gene amplification with metastatic potential and clinical outcomes in carcinomas},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
doi = {10.1152/ajpcell.00270.2024}
}
EUVIMED